Yesterday the Guardian published an article called ‘Miracle’ hepatitis C drugs costing £30k per patient ‘may have no clinical effect’
The problem with this sensationalist headline is that while it is reporting what was said by the Cochrane Collaboration what they looked at was trial specifically designed to test SVR rates, and not specifically designed to look at long-term outcomes.
Here is a commentary from Dr Andrew Hill and the study to which he refers which was presented at AASLD in 2015 and published in Clinical Infectious Diseases.
Total rubbish! Here is our paper showing a really strong correlation between curing HCV and improved survival.
They only had 16 deaths included in the analysis!
Please see the attached paper where we had much longer follow up and showed a strong effect of SVR on improved survival. Our analysis included 2210 deaths – slightly more than the Cochrane study!
